Skip to main content

Part of the book series: Current Clinical Practice ((CCP))

  • 1161 Accesses

Abstract

Herpes simplex virus (HSV) has a long and confusing history. More than 2500 years ago, Hippocrates first used the word “herpes,” derived from the Greek word “to creep,” to describe how the lesions of this contagious ulcerative disease seemed to creep or crawl along the skin (1). Galen first noted that recurrences develop at the same anatomic site. However, overtime, the word herpes was used to describe many skin conditions from lupus to zoster. The definition of herpes (particularly oral lesions) became more rigorous in the 17th century. In the 1830s, recurrent genital herpes was described and 60 years later was identified as a “vocational disease”—a sexually transmitted infection (STI). The virus itself was not identified until the 1950s. In 1971, it was proposed that two different types of HSV caused infection. HSV-1 commonly causes labial or pharyngeal infection, and transmission is primary by nongenital contact. HSV-2 typically affects the genital area and is transmitted by intimate sexual contact. However, both viruses are capable of causing either genital or oral-pharyngeal infections that appear identical on examination. In the United States, HSV infection is one of the most common STIs and is the leading cause of genital ulcers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Roizman B, Whitley RJ. The nine ages of herpes simplex virus. Herpes 2001; 8:23–27.

    CAS  PubMed  Google Scholar 

  2. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296(8):964–973.

    Article  CAS  PubMed  Google Scholar 

  3. Yeung-Yue KA, Brentjens MH, Lee PC, Tyring SK. Herpes simplexviruses 1 and 2. Dermatol Clin 2002; 20:249–266.

    Article  PubMed  Google Scholar 

  4. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116:197–202.

    Article  CAS  PubMed  Google Scholar 

  5. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11–20.

    Article  CAS  PubMed  Google Scholar 

  6. National Institute of Allergy and Infectious Diseases. Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. Washington, DC: National Institutes of Health, Department of Health Services; 2001. Available from: http://www.niaid.nih.gov/dmid/stds/condomreport.pdf. Accessed June 4, 2005.

    Google Scholar 

  7. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva: World Health Organization; 2001. Available from: http://www.who.int/emc-documents/STIs/whocdscsredc200110c.html Accessed July 10, 2005.

    Google Scholar 

  8. Schacker T. The role of HSV in the transmission and progression of HIV. Herpes 2001; 8: 46–49.

    CAS  PubMed  Google Scholar 

  9. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998; 280:61–66.

    Article  CAS  PubMed  Google Scholar 

  10. Mole L, Ripich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997; 176:766–770.

    Article  CAS  PubMed  Google Scholar 

  11. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45–52.

    Article  PubMed  Google Scholar 

  12. Wald A. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes 2004; 11:130A–137A.

    PubMed  Google Scholar 

  13. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285:3100–3106.

    Article  CAS  PubMed  Google Scholar 

  14. Cherpes TL, Meyn LA, Krohn MA, Hillier SL. Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis 2003; 30:405–410.

    Article  PubMed  Google Scholar 

  15. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341:1432–1438.

    Article  CAS  PubMed  Google Scholar 

  16. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000; 181:1454–1457.

    Article  CAS  PubMed  Google Scholar 

  17. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342:844–850.

    Article  CAS  PubMed  Google Scholar 

  18. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 1997; 99:1092–1097.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Bryson Y, Dillon M, Bernstein DI, Radolf J, Zakowski P, Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 1993; 167:942–946.

    Article  CAS  PubMed  Google Scholar 

  20. Koelle DM, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 1992; 116: 433–437.

    Article  CAS  PubMed  Google Scholar 

  21. Scoular A. Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sex Transm Infect 2002; 78:160–165.

    Article  CAS  PubMed  Google Scholar 

  22. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic firstepisode infection. Ann Intern Med 1994; 121:847–854.

    Article  CAS  PubMed  Google Scholar 

  23. Kimberlin DW, Rouse DJ. Clinical practice. Genital herpes. N Engl J Med 2004; 350:1970–1977.

    Article  CAS  PubMed  Google Scholar 

  24. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983; 98:958–972.

    Article  CAS  PubMed  Google Scholar 

  25. Patel R, Boselli F, Cairo I, Barnett G, Price M, Wulf HC. Patients’ perspectives on the burden of recurrent genital herpes. Int J STD AIDS 2001; 12:640–645.

    Article  CAS  PubMed  Google Scholar 

  26. Sweet RL, Gibbs RS. Herpes simplex virus infection. In: Infectious Diseases of the Female Genital Tract, 4th Ed. Philadelphia, PA: Lippincott, Williams &Wilkins, 2002; pp. 101–117.

    Google Scholar 

  27. Kessler HA, Baker DA, Brown ZA, Leone PA. Herpesvirus management: special considerations for the female patient. A monograph based on a symposium held May 6, 2002. New York, NY: New World Health; 2002.

    Google Scholar 

  28. Ebel C, Wald A. Managing Herpes: How to Live and Love with a Chronic STD, 3rd Ed. Research Park Triangle, NC: American Social Health Association; 2002.

    Google Scholar 

  29. Schacker T. The role of HSV in the transmission and progression of HIV. Herpes 2001; 8(2):46–49.

    CAS  PubMed  Google Scholar 

  30. Kaufman RH, Gardner HL, Rawls WE, Dixon RE, Young RL. Clinical features of herpes genitalis. Cancer Res 1973; 33:1446–1451.

    CAS  PubMed  Google Scholar 

  31. Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999; 131:14–20.

    Article  CAS  PubMed  Google Scholar 

  32. Fleming DT, Leone P, Esposito D. Herpes virus infection and genital symptoms in primary care patients. Sex Transm Inf 2006; 33(7):416–421.

    Google Scholar 

  33. Waggoner-Fountain LA, Grossman LB. Herpes simplex virus. Pediatr Rev 2004; 25:86–93.

    Article  PubMed  Google Scholar 

  34. Crist GA, Langer JM, Woods GL, Procter M, Hillyard DR. Evaluation of the ELVIS plate method for the detection and typing of herpes simplex virus in clinical specimens. Diagn Microbiol Infect Dis 2004; 49:173–177.

    Article  CAS  PubMed  Google Scholar 

  35. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002; 51:1–78.

    Google Scholar 

  36. Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. JAMA 1998; 280:887–892.

    Article  CAS  PubMed  Google Scholar 

  37. Tyring SK, Baker D, Snowden W. Valacyclovir for herpes simplex virus infection: longterm safety and sustained efficacy after 20 years experience with acyclovir. J Infect Dis 2002; 186:S40–46.

    Article  CAS  PubMed  Google Scholar 

  38. Parks DG, Greenway FL, Pack AT. Prevention of recurrent herpes simplex type II infection with lithium carbonate. Med Sci Research 1988; 16:971–972.

    Google Scholar 

  39. Alexander L, Naisbett B. Patient and physician partnerships in managing genital herpes. J Infect Dis 2002; 186:S57–S65.

    Article  PubMed  Google Scholar 

  40. Brown ZA, Gardella C, Wald A, Morrow RA, Corey L. Genital herpes complicating pregnancy. Obstet Gynecol 2005; 106(4):845–856.

    Article  PubMed  Google Scholar 

  41. Eskild A, Jeansson S, Stray-Pedersen B, Jenum PA. Herpes simplex virus type-2 infection in pregnancy: no risk of fetal death: results from a nested case-control study within 35,940 women. BJOG 2002; 109:1030–1035.

    PubMed  Google Scholar 

  42. Brown Z. Preventing herpes simplex virus transmission to the neonate. Herpes 2004; 11: 175A–186A.

    PubMed  Google Scholar 

  43. Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev 2004; 17(1): 1–13.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Smith JR, Cowan FM, Munday P. The management of herpes simplex virus infection in pregnancy. Br J Obstet Gynaecol 1998; 105:255–260.

    Article  CAS  PubMed  Google Scholar 

  45. Watts DH, Brown ZA, Money D, et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003; 188:836–843.

    Article  CAS  PubMed  Google Scholar 

  46. Thung SF, Grobman WA. The cost-effectiveness of routine antenatal screening for maternal herpes simplex virus-1 and-2 antibodies. Am J Obstet Gynecol 2005; 192:483–488.

    Article  PubMed  Google Scholar 

  47. Baker D, Brown Z, Hollier LM, et al. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am J Obstet Gynecol 2004; 191:2074–2084.

    Article  CAS  PubMed  Google Scholar 

  48. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of herpes in pregnancy. Number 8 October 1999. Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 2000; 68:165–173.

    Article  Google Scholar 

  49. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 2003; 102: 1396–1403.

    Article  CAS  PubMed  Google Scholar 

  50. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652–1661.

    Article  CAS  PubMed  Google Scholar 

  51. Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143(10):707–713.

    Article  PubMed  Google Scholar 

  52. Rana RK, Pimenta JM, Rosenberg DM, et al. Sexual behaviour and condom use among individuals with a history of symptomatic genital herpes. Sex Transm Inf 2006; 82(1):69–74.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.,Totowa NJ

About this chapter

Cite this chapter

Parks, G. (2006). Genital Herpes. In: Nelson, A.L., Woodward, J., Wysocki, S. (eds) Sexually Transmitted Diseases. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-040-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-040-9_3

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-58829-570-5

  • Online ISBN: 978-1-59745-040-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics